NCT01762865

Brief Summary

The investigators hypothesized that acute bronchitis will be associated with various bacteria and viruses.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2012

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2012

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

January 6, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 8, 2013

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2013

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2013

Completed
Last Updated

January 8, 2013

Status Verified

January 1, 2013

Enrollment Period

1.3 years

First QC Date

January 6, 2013

Last Update Submit

January 7, 2013

Conditions

Acute Bronchitis

Keywords

acute bronchitis, bacteria, virus, clinical symoptoms

Outcome Measures

Primary Outcomes (1)

  • Microorganisms (bacteria and/or viruses) related to acute bronchitis

    Outcome measure is just type of microoganisms from collected specimens at hospital visit

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

adult patinets who visit hospitals for recent sputum and/or cough

You may qualify if:

  • Adults patients aged over 18 years.
  • Patients who complain of recent sputum and cough.

You may not qualify if:

  • Patinets who took antibiotics within 7 days.
  • Patinets whose symptoms last for \< 5 days.
  • Patients who have definite cause of acute cough such as pneumonia, allergic rhinnits, sinusitis, GERD and drug.
  • Immunocompromised patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Chunchon Sacred Heart Hospital

Chunchon, Gangwon-do, 200-704, South Korea

RECRUITING

Pumonary, Allegry and Critical Care Medicine; Hallym University Sacred Heart Hospital

Anyang-si, Gyeonggi-do, 431-070, South Korea

RECRUITING

Kandong Sacred Heart Hospital

Seoul, Seoul, 134-814, South Korea

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Sputum specimens for microbiologic tests

MeSH Terms

Conditions

BronchitisVirus Diseases

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung Diseases

Study Officials

  • Ki-Suck Jung, MD, PhD

    Pulmonary, Allgery and Critical Care Medicine; Hallym University Sacred Heart Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sunghoon Park, MD, PhD

CONTACT

82-31-380-3803f2000tj@gmail.com

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 6, 2013

First Posted

January 8, 2013

Study Start

April 1, 2012

Primary Completion

August 1, 2013

Study Completion

October 1, 2013

Last Updated

January 8, 2013

Record last verified: 2013-01

Locations

KR(3)